Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

EGFR tyrosine kinase inhibitor from Novartis will proceed to clinical testing

April 9, 1998

Chemistry of new immunosuppressive triterpenoid elucidated by Merck & Co.

April 9, 1998

Novel topoisomerase I inhibitor discovered at Kaken

April 8, 1998

Symphar antineoplastic agent induces apoptosis and reverses MDR

April 8, 1998

Aspartame has potent antiarthritic activity in preclinical models and arthritic subjects

April 8, 1998

Heparinase I pharmacokinetics evaluated in healthy volunteers

April 8, 1998

Ro-25-3036 improves dosing frequency of IFN in hepatitis patients

April 8, 1998

Factor Xa inhibitor selected for clinical trials at Berlex Biosciences

April 8, 1998

New factor Xa inhibitors designed at DuPont Merck

April 8, 1998

HBOC-201 reduces need for blood transfusions in surgery

April 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...